Reduced expression of the cystic fibrosis transmembrane conductance regulator gene in the hypothalamus of patients with Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 5, Issue 6, 2003, Pages 455-462

  Lahousse, Stephanie A ^b   Stopa, Edward G ^b   Mulberg, Andrew E ^b   De La Monte, Suzanne M ^a  

^a RHODE ISLAND HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; COMPLEMENTARY RNA; MESSENGER RNA; TRANSMEMBRANE CONDUCTANCE REGULATOR;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PRIORITY JOURNAL;

EID: 0345873303     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/jad-2003-5605     Document Type: Article

References (45)

1. B. Kerem and E. Kerem, The molecular basis for disease variability in cystic fibrosis, Eur J Hum Genet 4(2) (1996), 65-73.
2. G.R. Cutting, Spectrum of mutations in cystic fibrosis, J Bioenerg Biomembr 25(1) (1993), 7-10.
3. M.L. Drumm and F.S. Collins, Molecular biology of cystic fibrosis, Mol Genet Med 3 (1993), 33-68.
4. I. McIntosh and G.R. Cutting, Cystic fibrosis transmembrane conductance regulator and the etiology and pathogenesis of cystic fibrosis, Faseb J 6(10) (1992), 2775-2782.
5. J.R. Riordan, J.M. Rommens, B. Kerem, N. Alon, R. Rozmahel and Z. Grzelczak et al., Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA, Science 245(4922) (1989), 1066-1073.
6. J.A. Cohn, T.V. Strong, M.R. Picciotto, A.C. Naim, F.S. Collins and J.G. Fitz, Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells, Gastroenterology 105(6) (1993), 1857-1864.
7. J.F. Engelhardt, J.R. Yankaskas, S.A. Ernst, Y. Yang, C.R. Marino and R.C. Boucher et al., Submucosal glands are the predominant site of CFTR expression in the human bronchus, Nat Genet 2(3) (1992), 240-248.
8. A. Harris, Cystic fibrosis transmembrane conductance regulator (CFTR) gene transcripts, Embo J 11(1) (1992), 379-380.
9. A.E. Mulberg, R.T. Weyler, S.M. Altschuler and T.M. Hyde, Cystic fibrosis transmembrane conductance regulator expression in human hypothalamus, Neuroreport 9(1) (1998), 141-144.
10. A.E. Mulberg, E.B. Wiedner, X. Bao, J. Marshall, D.M. Jefferson and S.M. Altschuler, Cystic fibrosis transmembrane conductance regulator protein expression in brain, Neuroreport 5(13) (1994), 1684-1688.
11. T.V. Strong, K. Boehm and F.S. Collins, Localization of cystic fibrosis transmembrane conductance regulator mRNA in the human gastrointestinal tract by in situ hybridization, J Clin Invest 93(1) (1994), 347-354.
12. E.F. Tizzano, D. Chitayat and M. Buchwald, Cell-specific localization of CFTR mRNA shows developmentally regulated expression in human fetal tissues, Hum Mol Genet 2(3) (1993), 219-224.
13. A.E. Trezise, J.A. Chambers, C.J. Wardle, S. Gould and A. Harris, Expression of the cystic fibrosis gene in human foetal tissues, Hum Mol Genet 2(3) (1993), 213-218.
14. J.A. Whitsett, C.R. Dey, B.R. Stripp, K.A. Wikenheiser, J.C. Clark and S.E. Wert et al., Human cystic fibrosis transmembrane conductance regulator directed to respiratory epithelial cells of transgenic mice, Nat Genet 2(1) (1992), 13-20.
15. P. Hart, J.D. Warth, P.C. Levesque, M.L. Collier, Y. Geary and B. Horowitz et al., Cystic fibrosis gene encodes a cAMP-dependent chloride channel in heart, Proc Natl Acad Sci USA 93(13) (1996), 6343-6348.
16. S. Nousia-Arvanitakis, Cystic fibrosis and the pancreas: recent scientific advances, J Clin Gastroenterol 29(2) (1999), 138-142.
17. I. Crawford, P.C. Maloney, P.L. Zeitlin, W.B. Guggino, S.C. Hyde and H. Turley et al., Immunocytochemical localization of the cystic fibrosis gene product CFTR, Proc Natt Acad Sci USA 88(20) (1991), 9262-9266.
18. X. Wei, R. Eisman, J. Xu, A.D. Harsch, A.E. Mulberg and C.L. Bevins et al., Turnover of the cystic fibrosis transmembrane conductance regulator (CFTR): slow degradation of wild-type and delta F508 CFTR in surface membrane preparations of immortalized airway epithelial cells, J Cell Physiol 168(2) (1996), 373-384.
19. N.A. Bradbury, cAMP signaling cascades and CFTR: is there more to learn? Pflugers Arch 443(Suppl 1) (2001), S85-91.
20. J.Y. Choi, D. Muallem, K. Kiselyov, M.G. Lee, P.J. Thomas and S. Muallem, Aberrant CFTR-dependent HCO3-transport in mutations associated with cystic fibrosis, Nature 410(6824) (2001), 94-97.
21. E.M. Schwiebert, D.J. Benos, M.E. Egan, M.J. Stutts and W.B. Guggino, CFTR is a conductance regulator as well as a chloride channel, Physiol Rev 79(1 Suppl) (1999), S145-166.
22. A.E. Mulberg, L.P. Resta, E.B. Wiedner, S.M. Altschuler, D.M. Jefferson and D.L. Broussard, Expression and localization of the cystic fibrosis transmembrane conductance regulator mRNA and its protein in rat brain, J Clin Invest 96(1) (1995), 646-652.
23. S.J. Cavalier and P. Gambetti, Dystrophic axons and spinal cord demyelination in cystic fibrosis, Neurology 31(6) (1981), 714-718.
24. J.H. Sung, S.H. Park, A.R. Mastri and W.J. Warwick, Axonal dystrophy in the gracile nucleus in congenital biliary atresia and cystic fibrosis (mucoviscidosis): beneficial effect of vitamin E therapy, J Neuropathot Exp Neurol 39(5) (1980), 584-597.
25. J.H. Sung, A.R. Mastri and S.H. Park, Axonal dystrophy in the gracile nucleus in children and young adults. Reappraisal of the incidence and associated diseases, J Neuropathol Exp Neurol 40(1) (1981), 37-45.
26. E. Cochran, B. Bacci, Y. Chen, A. Patton, P. Gambetti and L. Autilio-Gambetti, Amyloid precursor protein and ubiquitin immunoreactivity in dystrophic axons is not unique to Alzheimer's disease, Am J Pathot 139(3) (1991), 485-489.
27. R.T. Weyler, K.A. Yurko-Mauro, R. Rubenstein, W.J. Kollen, W. Reenstra and S.M. Altschuler et al., CFTR is functionally active in GnRH-expressing GT1-7 hypothalamic neurons, Am J Physiot 277(3 Pt 1) (1999), C563-571.
28. J.E. Donahue, T.M. Berzin, M.S. Rafii, D.J. Glass, G.D. Yancopoulos and J.R. Fallon et al., Agrin in Alzheimer's disease: altered solubility and abnormal distribution within microvasculature and brain parenchyma, Proc Natl Acad Sci USA 96(11) (1999), 6468-6472.
29. E.G. Stopa, E.T. Koh, C.N. Svendsen, W.T. Rogers, J.S. Schwaber and J.C. King, Computer-assisted mapping of immunoreactive mammalian gonadotropin-releasing ormone in adult human basal forebrain and amygdala, Endocrinology 128(6) (1991), 3199-3207.
30. W. Byne, L. Mattiace, Y. Kress and P. Davies, Alz-50 immunoreactivity in the hypothalamus of the normal and Alzheimer human and the rat, J Comp Neurot 306(4) (1991), 602-612.
31. H. Braak and E. Braak, Neuropathological stageing of Alzheimer-related changes, Acta Neuropathol 82(4) (1991), 239-259.
32. S.M. de la Monte, W. Garner and J.R. Wands, Neuronal thread protein gene modulation with cerebral infarction, J Cereb Blood Flow Metab 17(6) (1997), 623-635.
33. S.M. de la Monte, K. Ghanbari, W.H. Frey, I. Beheshti, P. Averback and S.L. Hauser et al., Characterization of the AD7C-NTP cDNA expression in Alzheimer's disease and measurement of a 41-kD protein in cerebrospinal fluid, J Clin Invest 100(12) (1997), 3093-3104.
34. K. Maemura, S.M. de la Monte, M.T. Chin, M.D. Layne, C.M. Hsieh and S.F. Yet et al., CLIF, a novel cycle-like factor, regulates the circadian oscillation of plasminogen activator inhibitor-1 gene expression, J Biol Chem 275(47) (2000), 36847-36851.
35. S.P. Kalra, M.G. Dube, S. Pu, B. Xu, T.L. Horvath and P.S. Kalra, Interacting appetite-regulating pathways in the hypothalamic regulation of body weight, Endocrine Reviews 20(1) (1999), 68-100.
36. P.F. Van der Woude, E. Goudsmit, M. Wierda, J.S. Purba, M.A. Hofman and H. Bogte et al., No vasopressin cell loss in the human hypothalamus in aging and Alzheimer's disease, Neurobiol Aging 16(1) (1995), 11-18.
37. E. Goudsmit, M.A. Hofman, E. Fliers and D.F. Swaab, The supraoptic and paraventricular nuclei of the human hypothalamus in relation to sex, age and Alzheimer's disease, Neurobiol Aging 11(5) (1990), 529-536.
38. M. Mall, A. Wissner, H.H. Seydewitz, J. Kuehr, M. Brandis and R. Greger et al., Defective cholinergic Cl(-) secretion and detection of K(+) secretion in rectal biopsies from cystic fibrosis patients, Am J Physiol Gastrointest Liver Physiol 278(4) (2000), G617-624.
39. U. Seidler, I. Blumenstein, A. Kretz, D. Viellard-Baron, H. Rossmann and W.H. Colledge et al., A functional CFTR protein is required for mouse intestinal cAMP-, cGMP-, and Ca(2+)-dependent HCO3- secretion, J Physiol 505(Pt 2) (1997), 411-423.
40. R.A. Frizzell, Functions of the cystic fibrosis transmembrane conductance regulator protein, Am J Respir Crit Care Med 151(3 Pt 2) (1995), S54-58.
41. V. Urbach and B.J. Harvey, Regulation of intracellular Ca(2+) by CFTR in Chinese hamster ovary cells, J Membr Biol 171(3) (1999), 255-265.
42. J.K. Bubien, CFTR may play a role in regulated secretion by lymphocytes: a new hypothesis for the pathophysiology of cystic fibrosis, Pflugers Arch 443(1) (2001), S36-39.
43. A.G. Prat, I.L. Reisin, D.A. Ausiello and H.F. Cantiello, Cellular ATP release by the cystic fibrosis transmembrane conductance regulator, Am J Physiol 270(2 Pt 1) (1996), C538-545.
44. P.T. Rowley, S. Loader and J.C. Levenkron, Cystic fibrosis carrier population screening: a review, Genet Test 1(1) (1997), 53-59.
45. D.F. Swaab, M.A. Hofman, P.J. Lucassen, J.S. Purba, F.C. Raadsheer and J.A. Van de Nes, Functional neuroanatomy and neuropathology of the human hypothalamus, Anat Embryol (Bert) 187(4) (1993), 317-330.